Keurig Dr Pepper (NASDAQ:KDP) Price Target Raised to $40.00

Keurig Dr Pepper (NASDAQ:KDP) had its target price raised by JPMorgan Chase & Co. from $37.00 to $40.00 in a research note issued to investors on Wednesday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Other equities analysts have also issued research reports about the stock. Barclays restated an “overweight” rating and set a $36.00 target price on shares of Keurig Dr Pepper in a report on Tuesday. Piper Sandler began coverage on Keurig Dr Pepper in a research report on Tuesday. They issued a “neutral” rating and a $35.00 target price for the company. UBS Group reiterated a “buy” rating on shares of Keurig Dr Pepper in a research note on Tuesday. Deutsche Bank Aktiengesellschaft raised Keurig Dr Pepper from a “hold” rating to a “buy” rating and boosted their price target for the stock from $37.00 to $39.00 in a research report on Thursday, December 12th. Finally, TD Cowen lowered their price objective on shares of Keurig Dr Pepper from $39.00 to $36.00 and set a “hold” rating for the company in a research report on Wednesday, January 8th. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Keurig Dr Pepper currently has a consensus rating of “Moderate Buy” and an average target price of $38.23.

Keurig Dr Pepper Stock Performance

Keurig Dr Pepper stock opened at $33.52 on Wednesday. The company has a market cap of $45.47 billion, a price-to-earnings ratio of 20.32, a price-to-earnings-growth ratio of 2.42 and a beta of 0.61. Keurig Dr Pepper has a 12 month low of $28.61 and a 12 month high of $38.28. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.53 and a quick ratio of 0.36. The stock’s 50-day moving average is $31.93 and its 200-day moving average is $33.93.

Keurig Dr Pepper (NASDAQ:KDP) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.57 by $0.01. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The firm had revenue of $4.07 billion for the quarter, compared to analyst estimates of $4.01 billion. During the same quarter last year, the firm posted $0.55 earnings per share. Keurig Dr Pepper’s revenue for the quarter was up 5.2% compared to the same quarter last year. Equities analysts anticipate that Keurig Dr Pepper will post 1.92 earnings per share for the current year.

Keurig Dr Pepper Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a $0.23 dividend. This represents a $0.92 annualized dividend and a dividend yield of 2.74%. The ex-dividend date is Friday, March 28th. Keurig Dr Pepper’s payout ratio is currently 55.76%.

Insider Transactions at Keurig Dr Pepper

In other news, major shareholder Bevco B.V. Jab purchased 3,619,600 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The shares were acquired at an average cost of $33.34 per share, with a total value of $120,677,464.00. Following the transaction, the insider now owns 218,063,479 shares in the company, valued at approximately $7,270,236,389.86. The trade was a 1.69 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.00% of the company’s stock.

Institutional Trading of Keurig Dr Pepper

Institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its holdings in shares of Keurig Dr Pepper by 23.6% in the 4th quarter. Vanguard Group Inc. now owns 119,587,162 shares of the company’s stock valued at $3,841,140,000 after buying an additional 22,856,757 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in Keurig Dr Pepper by 36.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company’s stock worth $1,755,564,000 after acquiring an additional 14,473,054 shares during the last quarter. FMR LLC boosted its stake in Keurig Dr Pepper by 9.8% in the third quarter. FMR LLC now owns 102,183,144 shares of the company’s stock valued at $3,829,824,000 after acquiring an additional 9,105,164 shares during the period. Barrow Hanley Mewhinney & Strauss LLC grew its holdings in shares of Keurig Dr Pepper by 65.0% during the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 21,219,771 shares of the company’s stock valued at $681,579,000 after purchasing an additional 8,363,192 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of Keurig Dr Pepper during the 4th quarter worth approximately $197,819,000. Institutional investors own 93.99% of the company’s stock.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.